4Accepted Sep 4, 9:08 AM ET
Johnson & Johnson (JNJ) EVP Timothy Schmid Exercises Options, Sells Shares
Accepted (ET)
9:08 AM
Sep 4, 2026
Filed
Sep 4, 2026
Documents
1
Size
14.9 KB
Summary
Johnson & Johnson (JNJ) EVP Timothy Schmid Exercises Options, Sells Shares
What Happened
Timothy Schmid, EVP and Worldwide Chair, MedTech at Johnson & Johnson, exercised stock options and immediately sold the acquired shares on September 2, 2026. He exercised 11,070 options at $131.94 ($1,460,576) and 22,527 options at $151.41 ($3,410,813), acquiring a total of 33,597 shares. Those 33,597 shares were sold in open-market transactions at $274.74 per share for combined gross proceeds of $9,230,440. After accounting for the exercise costs (~$4,871,389), the transaction produced roughly $4,359,051 in proceeds before taxes and fees.
Key Details
- Transaction date: 2026-09-02 (Form 4 filed 2026-09-04; appears timely)
- Option exercises:
- 11,070 shares exercised at $131.94 — cost $1,460,576
- 22,527 shares exercised at $151.41 — cost $3,410,813
- Open-market sales:
- 11,070 shares sold at $274.74 — proceeds $3,041,372
- 22,527 shares sold at $274.74 — proceeds $6,189,068
- Additional derivative entries show dispositions of 11,070 and 22,527 shares at $0.00 (likely share surrender/net settlement for taxes or option payment as recorded in the filing).
- Shares owned after the transactions are not specified in the excerpt provided.
- Footnotes:
- F3: Awards were under the issuer's Long-Term Incentive Plan (options vest/exercisable on the third anniversary of grant).
- F1/F2: Some holdings reported include amounts from the company savings/ESOP plans as of 8/31/2026.
Context
- This is a common cashless-style sequence: exercise of options followed by an immediate open-market sale to cover exercise costs and tax obligations. Such transactions are routine and do not alone indicate executive sentiment about the company.
- Derivative code M indicates option exercise/conversion. The zero-dollar dispositions likely reflect shares used to satisfy exercise payment or tax withholding rather than a separate sale.
- This filer is an executive (not a 10% owner), and the activity appears to stem from vested long-term incentive awards rather than a private transfer or gift.